We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Precision BioSciences Inc | NASDAQ:DTIL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.29 | -2.65% | 10.64 | 10.26 | 10.75 | 11.00 | 10.23 | 10.90 | 41,703 | 01:00:00 |
| | | | | S-1 | | | |
| | | | | S-2 | | | |
| | | | | S-5 | | | |
| | | | | S-7 | | | |
| | | | | S-10 | | | |
| | | | | S-13 | | | |
| | | | | S-14 | | | |
| | | | | S-15 | | | |
| | | | | S-17 | | | |
| | | | | S-25 | | | |
| | | | | S-29 | | | |
| | | | | S-37 | | | |
| | | | | S-38 | | | |
| | | | | S-39 | | | |
| | | | | S-40 | | |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 4 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 7 | | | |
| | | | | 11 | | | |
| | | | | 19 | | | |
| | | | | 21 | | | |
| | | | | 22 | | | |
| | | | | 26 | | | |
| | | | | 28 | | | |
| | | | | 28 | | |
|
Public offering price per share
|
| | | | | | | | | $ | | | |
|
Net tangible book value per share as of September 30, 2023
|
| | | $ | 7.29 | | | | | | | | |
|
Pro forma increase in net tangible book value per share attributable to the issuance of 97,360 shares of our common stock to TG Therapeutics
|
| | | | 0.40 | | | | | | | | |
|
Pro forma net tangible book value per share as of September 30, 2023
|
| | | | 7.69 | | | | | | | | |
|
Increase in pro forma net tangible book value per share after giving effect to the offering
|
| | | | | | | | | | | | |
|
Pro forma as adjusted net tangible book value per share as of September 30, 2023
|
| | | | | | | | | | | | |
|
Dilution per share to new investors participating in the offering
|
| | | | | | | | | $ | | | |
| | |
Per
Share and Accompanying Warrant |
| |
Per Pre-funded
Warrant and Accompanying Warrant |
| |
Total
|
| |||||||||
Combined Public offering price
|
| | | $ | | | | | $ | | | | | $ | | | |||
Underwriting discounts and commissions paid by us
|
| | | $ | | | | | $ | | | | | $ | | | |||
Proceeds to us, before expenses
|
| | | $ | | | | | $ | | | | | $ | | | |
| | |
Page
|
| |||
| | | | 1 | | | |
| | | | 2 | | | |
| | | | 4 | | | |
| | | | 5 | | | |
| | | | 6 | | | |
| | | | 7 | | | |
| | | | 11 | | | |
| | | | 19 | | | |
| | | | 21 | | | |
| | | | 22 | | | |
| | | | 26 | | | |
| | | | 28 | | | |
| | | | 28 | | |
1 Year Precision BioSciences Chart |
1 Month Precision BioSciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions